Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
NCT ID: NCT01746537
Last Updated: 2025-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2012-06-30
2029-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
NCT07065747
Objective Choroidal Thickness Measurements in Uveitis
NCT03889860
Optical Coherence Tomography (OCT) in Uveitis
NCT02026128
Imaging Quantification of Inflammation (IQI)
NCT04704609
Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
NCT02907814
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe corneal opacities preventing imaging of anterior chamber
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sunil Srivastava
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sunil K Srivastva, MD
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cole Eye Institute
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Sunil K Srivastava, M.D.
Role: CONTACT
Kimberly M Baynes, BSN, RN
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sunil K Srivastava, M.D.
Role: primary
Kimberly M Baynes, BSN,RN
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-612
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.